<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">49882</article-id><article-id pub-id-type="doi">10.7554/eLife.49882</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Obesity-linked suppression of membrane-bound <italic>O</italic>-Acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-149264"><name><surname>Helsley</surname><given-names>Robert N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5000-3187</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149266"><name><surname>Venkateshwari</surname><given-names>Varadharajan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109966"><name><surname>Brown</surname><given-names>Amanda L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149265"><name><surname>Gromovsky</surname><given-names>Anthony D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109964"><name><surname>Schugar</surname><given-names>Rebecca C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159768"><name><surname>Ramachandiran</surname><given-names>Iyappan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159769"><name><surname>Fung</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109965"><name><surname>Kabbany</surname><given-names>Mohammad Nasser</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149267"><name><surname>Banerjee</surname><given-names>Rakhee</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143637"><name><surname>Neumann</surname><given-names>Chase K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109967"><name><surname>Finney</surname><given-names>Chelsea</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149268"><name><surname>Pathak</surname><given-names>Preeti</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149269"><name><surname>Danny</surname><given-names>Orabi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160869"><name><surname>Osborn</surname><given-names>Lucas J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149271"><name><surname>Massey</surname><given-names>William</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109968"><name><surname>Zhang</surname><given-names>Renliang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149272"><name><surname>Kadam</surname><given-names>Anagha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109969"><name><surname>Sansbury</surname><given-names>Brian E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22106"><name><surname>Pan</surname><given-names>Calvin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109970"><name><surname>Sacks</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109971"><name><surname>Lee</surname><given-names>Richard G</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-109972"><name><surname>Crooke</surname><given-names>Rosanne M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-109973"><name><surname>Graham</surname><given-names>Mark J</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-109974"><name><surname>Lemieux</surname><given-names>Madeleine E</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149273"><name><surname>Gogonea</surname><given-names>Valentin</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149274"><name><surname>Kirwan</surname><given-names>John P</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109976"><name><surname>Allende</surname><given-names>Daniela S</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-75429"><name><surname>Civelek</surname><given-names>Mete</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9840"><name><surname>Fox</surname><given-names>Paul L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109977"><name><surname>Rudel</surname><given-names>Lawrence L</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22114"><name><surname>Lusis</surname><given-names>Aldons J</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109978"><name><surname>Spite</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-51657"><name><surname>Brown</surname><given-names>Jonathan Mark</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2708-7487</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cardiovascular and Metabolic Sciences</institution>, <institution>Cleveland Clinic</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Center for Experimental Therapeutics and Reperfusion Injury</institution>, <institution>Brigham's and Womens Hospital, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Human Genetics, David Geffen School of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Pathobiology</institution>, <institution>Cleveland Clinic</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Cardiovascular Group</institution>, <institution>Ionis Pharmaceuticals Inc</institution>, <addr-line><named-content content-type="city">Carlsbad</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Cardiovasular Group</institution>, <institution>Ionis Pharmaceuticals Inc</institution>, <addr-line><named-content content-type="city">Carlsbad</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>Bioinfo</institution>, <addr-line><named-content content-type="city">Ontario</named-content></addr-line>, <country>Canada</country></aff><aff id="aff8"><institution content-type="dept">Department of Chemistry</institution>, <institution>Cleveland State University</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Department of Anatomical Pathology</institution>, <institution>Cleveland Clinic</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Department of Biomedical Engineering</institution>, <institution>University of Virginia</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff><aff id="aff11"><institution content-type="dept">Department of Pathology, Section on Lipid Sciences</institution>, <institution>Wake Forest University School of Medicine</institution>, <addr-line><named-content content-type="city">Winston-Salem</named-content></addr-line>, <country>United States</country></aff><aff id="aff12"><institution content-type="dept">Department of Medicine</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff13"><institution content-type="dept">Center for Experimental Therapeutics and Reperfusion Injury</institution>, <institution>Brigham's and Women's Hospital, Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1193"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role>Reviewing editor</role><aff><institution>University of California, Los Angeles</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>brownm5@ccf.org</email> (JB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>10</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e49882</elocation-id><history><date date-type="received"><day>03</day><month>07</month><year>2019</year></date><date date-type="accepted"><day>11</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Helsley et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Helsley et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-49882-v1.pdf"/><abstract><p>Recent studies have identified a genetic variant rs641738 near two genes encoding membrane bound <italic>O</italic>-acyltransferase domain-containing 7 (<italic>MBOAT7</italic>) and transmembrane channel-like 4 (<italic>TMC4</italic>) that associate with increased risk of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), alcohol-related cirrhosis, and liver fibrosis in those infected with viral hepatitis<sup>1-7</sup>. Based on hepatic expression quantitative trait loci analysis it has been suggested that <italic>MBOAT7</italic> loss of function promotes liver disease progression<sup>1-7</sup>, but this has never been formally tested. Here we show that <italic>Mboat7</italic> loss, but not <italic>Tmc4</italic>, in mice is sufficient to promote the progression of NAFLD in the setting of high fat diet. <italic>Mboat7</italic> loss of function is associated with accumulation of its substrate lysophosphatidylinositol (LPI) lipids, and direct administration of LPI promotes hepatic inflammatory and fibrotic transcriptional changes in an <italic>Mboat7</italic>-dependent manner. These studies reveal a novel role for MBOAT7-driven acylation of LPI lipids in suppressing the progression of NAFLD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01-HL122283</award-id><principal-award-recipient><name><surname>Brown</surname><given-names>Jonathan Mark</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R00-HL12172</award-id><principal-award-recipient><name><surname>Civelek</surname><given-names>Mete</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01-HL106173</award-id><principal-award-recipient><name><surname>Spite</surname><given-names>Matthew</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>F32-HL136044</award-id><principal-award-recipient><name><surname>Sansbury</surname><given-names>Brian E</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01-DK120679</award-id><principal-award-recipient><name><surname>Brown</surname><given-names>Jonathan Mark</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000027</institution-id><institution>National Institute on Alcohol Abuse and Alcoholism</institution></institution-wrap></funding-source><award-id>P50-AA-024333</award-id><principal-award-recipient><name><surname>Allende</surname><given-names>Daniela S</given-names></name><name><surname>Brown</surname><given-names>Jonathan Mark</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>P01 HL029582</award-id><principal-award-recipient><name><surname>Fox</surname><given-names>Paul L</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000027</institution-id><institution>National Institute on Alcohol Abuse and Alcoholism</institution></institution-wrap></funding-source><award-id>U01-AA021893</award-id><principal-award-recipient><name><surname>Allende</surname><given-names>Daniela S</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>U01-DK061732</award-id><principal-award-recipient><name><surname>Allende</surname><given-names>Daniela S</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01-DK103637</award-id><principal-award-recipient><name><surname>Allende</surname><given-names>Daniela S</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>P01-HL49373</award-id><principal-award-recipient><name><surname>Rudel</surname><given-names>Lawrence L</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>P01-HL30568</award-id><principal-award-recipient><name><surname>Lusis</surname><given-names>Aldons J</given-names></name></principal-award-recipient></award-group><funding-statement>All coauthors are responsible for the content of this work, and different aspects of this work was funded by the National Institutes of Health (NIH) and the American Heart Association (AHA).</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Richard G Lee, employee at Ionis Pharmaceuticals, Inc.</p></fn><fn fn-type="conflict" id="conf3"><p>Rosanne M Crooke, employee at Ionis Pharmaceuticals, Inc.</p></fn><fn fn-type="conflict" id="conf4"><p>Mark J Graham, employee at Ionis Pharmaceuticals, Inc.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Rat Studies of Diet-Induced ObesitySprague Dawley Rats were received at 12 weeks of age and were housed in individual cages, kept at a constant temperature and ambient humidity in a 12-hlight/dark cycle. Animals were then randomly assigned to either a standard chow diet or a high-fat diet (D12492, 60% fat, Research Diets, New Brunswick, NJ, USA) ad libitum to establish diet-induced obesity as previously described20. After 6 months of HFD-feeding, livers were excised for standard qPCR analysis of Mboat7 expression.Hybrid Mouse Diversity Panel92 inbred strains of 8-week-old male mice (180 individual mice) were fed a high fat, high sucrose diet (D12266B, Research Diets, New Brunswick, NJ) for 8 weeks before tissue collection44. Gene expression of Mboat7 in white adipose tissue and liver were measured and correlated with obesity related traits using biweight midcorrelation analysis as previously described4.Mouse Studies of Mboat7 Loss of FunctionTo explore the role of Mboat7 in diet-induced obesity, NAFLD progression, and insulin resistance, we utilized an in vivo knockdown approach in 8-week old adult mice. Selective knockdown of Mboat7 was accomplished using 2'-O-ethyl (cET) modified antisense oligonucleotides (ASO). All ASOs used in this work were synthesized, screened, and purified as described previously45 by Ionis Pharmaceuticals, Inc. (Carlsbad, CA). For Mboat7 knockdown studies, adult (8 week old) male C57BL/6 mice were purchased from Jackson Labs (Bar Harbor, ME USA), and maintained on either a standard rodent chow diet or a high fat diet (HFD, D12492 from Research Diets Inc.) and injected intraperitoneally biweekly with 12.5 mg/kg of either non-targeting control ASO or one of two independent ASOs directed against murine Mboat7 for a period of 20 weeks. Similar results were seen with two independent ASOs targeting different regions of the Mboat7 mRNA, hence key data using one Mboat7 ASO are shown. All rodents were maintained in an Association for the Assessment and Accreditation of Laboratory Animal Care, International-approved animal facility, and all experimental protocols were approved by the Institutional Animal Care and use Committee of the Cleveland Clinic (IACUC protocols # 2015-1519 and # 2018-2053).</p></fn><fn fn-type="other"><p>Human subjects: Human MBOAT7 Expression Levels in Lean and Obese SubjectsThe majority of subjects recruited to examine MBOAT7 expression levels were morbidly obese bariatric surgery patients, but we were able to obtain liver biopsies from 10 subjects with a BMI under 30 as normal weight controls. For recruitment, adult patients undergoing gastric bypass surgery at Wake Forest School of Medicine were consented via written consent and enrolled by a member of the study staff following institutionally approved IRB protocols as previously described41. Exclusion criteria included: positive hepatitis C antibody, positive hepatitis B surface antigen, history of liver disease other than NAFLD, Childs A, B, or C cirrhosis, past or present diagnosis/treatment of malignancy other than non-melanocytic skin cancer, INR greater than 1.8 at baseline or need for chronic anticoagulation with warfarin or heparin products, use of immunomodulation for or history of inflammatory diseases including but not limited to malignancy, rheumatoid arthritis, psoriasis, lupus, sarcoidosis and inflammatory bowel disease, and greater or equal to 7 alcohol drinks per week or 3 alcoholic drinks in a given day each week. In addition to bariatric surgery patients, a small number of non-obese subjects (body mass index &lt;30.0) consented to liver biopsy during elective gall bladder removal surgery (n=10). Each subject was assigned a unique identifier which was used throughout the study and did not include any identifiable information about the patient such as name, address, telephone number, social security number, medical record number or any of the identifiers outlined in the HIPAA Privacy Rule regulations. Only the principal investigator had access to the code linking the unique identifier to the study subject. Basic clinical information was obtained via self-reporting and a 15 ml baseline blood sample was obtained at the time of enrollment. A subset of this cohort has been previously described20,41. At the time of surgery, the surgeon collected a roughly 1-gram sample from the lateral left lobe. Wedge biopsies were rinsed with saline and immediately snap frozen in liquid nitrogen in the operating room before subsequent storage at -80{degree sign}C. For data shown in Figure 7 showing levels of MBOAT7 substrate and product lipids, de-identified patient samples from the Cleveland Clinic hepatology clinic (IRB # 10-947) were analyzed. These patients had biopsy proven Ishak fibrosis scores42 of 0 (normal) or 4 (advanced fibrosis). For analysis of hepatic MBOAT7 expression, RNA isolated from liver biopsies were used for quantitative real time PCR (qPCR) as described below.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data have been deposited to the NCBI Gene Expression Omnibus, under the accession number GSE138947.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Helsley RN</collab><collab>Venkateshwari V</collab><collab>Brown AL</collab><collab>Gromovsky AD</collab><collab>Schugar RC</collab><collab>Ramachandiran I</collab><collab>Fung K</collab><collab>Kabbany MN</collab><collab>Banerjee R</collab><collab>Neumann CK</collab><collab>Finney C</collab><collab>Pathak P</collab><collab>Danny O</collab><collab>Osborn LJ</collab><collab>Massey W</collab><collab>Zhang R</collab><collab>Kadam A</collab><collab>Sansbury BE</collab><collab>Pan C</collab><collab>Sacks J</collab><collab>Lee RG</collab><collab>Crooke RM</collab><collab>Graham MJ</collab><collab>Lemieux ME</collab><collab>Gogonea V</collab><collab>Kirwan JP</collab><collab>Allende DS</collab><collab>Civelek M</collab><collab>Fox PL</collab><collab>Rudel LL</collab><collab>Lusis AJ</collab><collab>Spite M</collab><collab>Brown JM</collab></person-group><year iso-8601-date="2019">2019</year><source>Obesity-linked suppression of MBOAT7 promotes liver injury</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138947">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138947</ext-link><comment>NCBI GEO, GSE138947</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-49882-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>